New study may have identified an “off switch” for spike proteins produced in the body caused by mRNA injections

 Covid-19 mRNA “vaccines” have shown wider distribution in the body than initially claimed, raising concerns about unintended effects and the need for an “off switch” to stop ongoing spike protein production. A recent study identifies a treatment that may act as an “off switch.”

A preprint study led by Dr. Peter McCullough suggests using siRNA and RIBOTACs to target and degrade residual mRNA from covid-19 vaccines, potentially mitigating long-term health risks associated with persistent spike protein production.

The study proposes using siRNA and RIBOTACs as potential methods to bind to and degrade vaccine mRNA in cells, offering a targeted approach to prevent adverse events from mRNA-based therapies.

“Long vax” symptoms, similar to long covid, have been reported following vaccination, including fatigue, brain fog, numbness and cardiovascular issues, highlighting the need for effective treatments for those affected.

Another study led by McCullough found a significant increase in cerebral thromboembolism risk associated with covid-19 vaccines compared to other vaccines, leading to calls for a moratorium on their use....<<<Read More>>>...